- Role
- Country
- Date of registration
- Address
EUDAMED last updated this device on Aug 24, 2022
B-16438153819384FI-MF-000001479Primary placement in Finland; available across 25 countries total.
| Country | On market since | Until |
|---|---|---|
| FinlandPrimary placement | Feb 11, 2002 | May 26, 2027 |
| Cyprus | Feb 11, 2002 | Still on market |
| Austria | Feb 11, 2002 | May 26, 2027 |
| Belgium | Feb 11, 2002 | May 26, 2027 |
| Czechia | Feb 11, 2002 | May 26, 2027 |
| Germany | Feb 11, 2002 | May 26, 2027 |
| Estonia | Feb 11, 2002 | May 26, 2027 |
| EL | Feb 11, 2002 | May 26, 2027 |
| Spain | Feb 11, 2002 | May 26, 2027 |
| France | Feb 11, 2002 | May 26, 2027 |
| Hungary | Feb 11, 2002 | May 26, 2027 |
| Ireland | Feb 11, 2002 | May 26, 2027 |
| Italy | Feb 11, 2002 | May 26, 2027 |
| Liechtenstein | Feb 11, 2002 | May 26, 2027 |
| Lithuania | Feb 11, 2002 | May 26, 2027 |
| Luxembourg | Feb 11, 2002 | May 26, 2027 |
| Latvia | Feb 11, 2002 | May 26, 2027 |
| Malta | Feb 11, 2002 | May 26, 2027 |
| Poland | Feb 11, 2002 | May 26, 2027 |
| Portugal | Feb 11, 2002 | May 26, 2027 |
| Romania | Feb 11, 2002 | May 26, 2027 |
| Sweden | Feb 11, 2002 | May 26, 2027 |
| Slovakia | Feb 11, 2002 | May 26, 2027 |
| Türkiye | Feb 11, 2002 | May 26, 2027 |
| XI | Feb 11, 2002 | May 26, 2027 |
W0102010107IMMUNOGLOBULIN MCertificate health across this manufacturer's portfolio.
HX 1070846-1Supplemented